Epidemiologic Trends in Human Hepatitis A Virus Infection stratified by age between 2010 and 2018 in Cheonan, Korea
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Although studies on Hepatitis A virus (HAV) were crucial in the establishment of the HAV infection prevention programs, no systematic investigation into HAV has been conducted since 1999. We retrospectively analyzed the data between January 2010 to December 2018 from all the patients who underwent HAV antibody tests at the Dankook University Hospital Health Care Center. Data were collected from 56,204 individuals. Overall, 34,834 (62.0%) individuals from this cohort were positive for HAV antibodies and the annual rate of anti-HAV antibody positivity was highest in 2010 (68.5%) and lowest in 2013 (54.8%). The average decline in the antibody positivity rate was 0.62% per year, showing a statistically significant difference (p < 0.001). In the over 40s age group, anti-HAV antibody positivity rates decreased from 89% in 2010 to 64% in 2018 (p < 0.001), with an annual decrease of 3.1%. In the over 30s age group, it decreased from 48.2% in 2010 to 34.7% in 2018 (p < 0.001), with an annual decrease of 1.82%. This study shows that the antibody positivity rate is decreasing across age groups but given that HAV infection poses more significant risks in older patients it is important to expand the evaluations of the current and future antibody positivity rates for HAV in various age groups.
Abstract
Although studies on Hepatitis A virus (HAV) were crucial in the establishment of the HAV infection prevention programs, no systematic investigation into HAV has been conducted since 1999. We retrospectively analyzed the data between January 2010 to December 2018 from all the patients who underwent HAV antibody tests at the Dankook University Hospital Health Care Center. Data were collected from 56,204 individuals. Overall, 34,834 (62.0%) individuals from this cohort were positive for HAV antibodies and the annual rate of anti-HAV antibody positivity was highest in 2010 (68.5%) and lowest in 2013 (54.8%). The average decline in the antibody positivity rate was 0.62% per year, showing a statistically significant difference (p < 0.001). In the over 40s age group, anti-HAV antibody positivity rates decreased from 89% in 2010 to 64% in 2018 (p < 0.001), with an annual decrease of 3.1%. In the over 30s age group, it decreased from 48.2% in 2010 to 34.7% in 2018 (p < 0.001), with an annual decrease of 1.82%. This study shows that the antibody positivity rate is decreasing across age groups but given that HAV infection poses more significant risks in older patients it is important to expand the evaluations of the current and future antibody positivity rates for HAV in various age groups.
참고문헌 (21)
- Nainan OV, "Diagnosis of hepatitis A virus infection : a molecular approach", Clin. Microbiol. Rev, 19, pp.63~79 (2006)
- Cristina J, "Genetic variability and molecular evolution of Hepatitis A virus", Virus Res, 127, pp.151~157 (2007)
- Hadler SC, "Hepatitis A in day-care centers. A community-wide assessment", New Eng. J. Med, 302, pp.1222~1227 (1980)
- Ouardani I, "Detection and molecular characterization of hepatitis A virus from Tunisian wastewater treatment plants with different secondary treatments", Appl. Environ. Microbiol, 82, pp.3834~3845 (2016)
- Jacobsen KH, "The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns", Int. J. Epidemiol, 34, pp.600~609 (2005)
- Ouardani I, "Efficiency of hepatitis A virus removal in six sewage treatment plants from central Tunisia", Appl. Microbiol. Biotechnol, 99, pp.10759~10769 (2015)
- Korea Ministry of Health & Welfare, "Infectious Diseases Surveillance Yearbook", Publication Number: 11-1352159-000048-10, 21~ (2018)
- Cho KY, "Hepatitis A", Korean J. Pediatr. Gastroenterol. Nutr, 13, pp.S70~77 (2010)
- Weitz M, "Variation among hepatitis A virus strains. I. Genomic variation detected by T1 oligonucleotide mapping", Virus Res, 4(53), pp.53~67 (1985)
- 송영봉, "한국인 건강검진자에서 연령 특이적 A형간염바이러스 항체 혈청 양성률대한간학회지 제 13 권 제 1 호 2007 ; 27-33", Clinical and Molecular Hepatology, 13(1), pp.27~33 (2007), 대한간학회
- 이안나, "최근 4년 동안 전국의료기관에서 의뢰된 A형 간염바이러스 혈청 표지자 검사 결과에 대한 역학 분석", Annals of Laboratory Medicine, 29(6), pp.563~569 (2009), 대한진단검사의학회
- Ly KN, "Trends in disease and complications of hepatitis A virus infection in the United States, 1999-2011 : a new concern for adults", J. Infect. Dis, 212, pp.176~182 (2015)
- Altınkaynak S, "Epidemiological Factors affecting hepatitis A seroprevalence in childhood in a developing country", Eurasian J. Med, 40, pp.25~28 (2008)
- 김대현, "최근 10년간 광주？전남지역에서 발생한 A형 간염 환자의 임상적 특징", 대한내과학회지, 72(2), pp.131~137 (2007), 대한내과학회
- Laurence JC, "Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus", Am. J. Med, 118, pp.75S~83S (2005)
- Kim KA, "Nationwide seropositivity of Hepatitis A in Republic of Korea from 2005 to 2014, before and after the outbreak peak in 2009", PLoS One, 12, pp.e0170432~ (2017)
- Brundage SC, "Hepatitis A", Am. Fam. Physician, 73, pp.2162~2168 (2006)
- Kim JH, "Recent epidemiological status and vaccination of Hepatitis A in Korea", J. Korean Med. Assoc, 51, pp.110~118 (2008)
- Wang H, "Changing epidemiological characteristics of hepatitis A and warning of anti-HAV immunity in Beijing, China : a comparison of prevalence from 1990 to 2017", Hum. Vaccin. Immunother, 15, pp.420~425 (2019)
- Sa-nguanmoo P, "Declining trend of hepatitis A seroepidemiology in association with improved public health and economic status of Thailand", PLoS One, 11, pp.e0151304~ (2016)
- Tong MJ, "Clinical manifestations of hepatitis A: recent experience in a community teaching hospital", J. Infect. Dis, 171, pp.S15~S18 (1995)